\-\ Texto\\:\\ \ \(0\)\
\-\ none\\ provided\\.\ \(0\)\
\-\ small\\ asymptomatic\\ or\\ minimally\\ symptomatic\\ lesions\\ can\\ be\\ treated\\ conservatively\\ with\\ routine\\ follow\\ up\\ and\\ supportive\\ care\\.\\ \\ larger\\ symptomatic\\ lesions\\ may\\ be\\ resected\\ at\\ their\\ base\\ where\\ there\\ is\\ continuity\\ with\\ the\\ underlying\\ bone\\.\ \(0\)\
\-\ axial\\ ct\\ of\\ the\\ proximal\\ femurs\\ with\\ bone\\ windows\\ show\\ a\\ 1\\.5\\ x\\ 2\\.0\\ cm\\ osseous\\ lesion\\ projects\\ off\\ of\\ the\\ anterior\\ aspect\\ of\\ the\\ left\\ proximal\\ femur\\ just\\ below\\ the\\ greater\\ trochanter\\.\\ \\ the\\ lesion\\ demonstrates\\ medullary\\ and\\ cortical\\ continuity\\ with\\ the\\ normal\\ bone\\.\ \(0\)\
\-\ osteochondroma\ \(97\)\
\-\ hereditary\\ multiple\\ exostoses\\ \\(when\\ multiple\\)\ \(0\)\
\-\ the\\ patient\\ denied\\ any\\ pain\\ in\\ his\\ hips\\ or\\ thighs\\.\\ \\ the\\ lesion\\ in\\ his\\ left\\ femur\\ was\\ an\\ asymptomatic\\ incidental\\ finding\\.\ \(0\)\
\-\ the\\ femoral\\ bone\\ lesion\\ in\\ this\\ case\\ demonstrates\\ continuity\\ with\\ the\\ underlying\\ bone\\ cortex\\ and\\ medullary\\ canal\\ which\\ is\\ pathognomonic\\ for\\ an\\ osteochondroma\\.\\ \\ this\\ is\\ a\\ single\\ osteochondroma\\.\\ \\ if\\ multiple\\ osteochondromas\\ were\\ seen\\ in\\ this\\ patient\\,\\ hereditary\\ multiple\\ exostoses\\ \\ would\\ be\\ the\\ diagnosis\\.\\ \\ osteochondromas\\ enlarge\\ from\\ growth\\ at\\ the\\ cartilage\\ cap\\.\\ \\ upon\\ reaching\\ skeletal\\ maturity\\,\\ osteochondromas\\ usually\\ exhibit\\ no\\ further\\ growth\\.\\ \\ solitary\\ osteochondromas\\ are\\ estimated\\ to\\ occur\\ in\\ 1\\-2\\%\\ of\\ individuals\\ undergoing\\ routine\\ radiographic\\ evaluation\\.\\ \\ these\\ lesions\\ constitute\\ 20\\-50\\%\\ of\\ benign\\ bone\\ tumors\\ and\\ 10\\-15\\%\\ of\\ all\\ bone\\ tumors\\.\\ \\ as\\ in\\ this\\ case\\,\\ most\\ osteochondromas\\ are\\ asymptomatic\\.\\ \\ symptomatic\\ lesions\\ usually\\ occur\\ in\\ younger\\ patients\\.\\ \\ the\\ most\\ common\\ symptoms\\ is\\ a\\ nontender\\,\\ painless\\ cosmetic\\ deformity\\ related\\ to\\ enlarging\\ exophytic\\ mass\\.\\ \\ the\\ patient\\ in\\ this\\ case\\ was\\ a\\ male\\,\\ and\\ solitary\\ osteochondromas\\ have\\ a\\ male\\ predilection\\ ranging\\ from\\ 1\\.6\\-3\\.4\\ to\\ 1\\ as\\ compared\\ to\\ women\\.\\ \\ \\ 50\\%\\ of\\ osteochondromas\\ \\ involve\\ the\\ long\\ bones\\ of\\ the\\ lower\\ extremity\\.\\ \\ the\\ femur\\ as\\ in\\ this\\ case\\ is\\ the\\ single\\ most\\ frequently\\ affected\\ bone\\ occurring\\ in\\ 30\\%\\ of\\ cases\\.\\ \\ distal\\ involvement\\ of\\ the\\ affected\\ bone\\ is\\ three\\ times\\ more\\ common\\ than\\ proximal\\ involvement\\.\\ \\ this\\ case\\ demonstrated\\ more\\ proximal\\ involvement\\.\\ \\ this\\ osteochondroma\\ affected\\ the\\ metaphysis\\ which\\ is\\ common\\ for\\ these\\ bone\\ lesions\\.\\ \\ involvement\\ of\\ the\\ diaphysis\\ is\\ rare\\.\\ \\ malignant\\ transformation\\ of\\ osteochondromas\\ occurs\\ in\\ approximately\\ 1\\%\\ of\\ solitary\\ lesions\\.\\ \\ transformation\\ is\\ most\\ commonly\\ due\\ to\\ chondrosarcoma\\ arising\\ in\\ the\\ cartilage\\ cap\\ of\\ the\\ lesion\\.\\ \\ in\\ rare\\ cases\\,\\ an\\ osteosarcoma\\ can\\ develop\\ at\\ the\\ base\\ of\\ the\\ osteochondroma\\â\\€\\™s\\ stalk\\.\\ \\ lesions\\ that\\ grow\\ or\\ cause\\ pain\\ after\\ skeletal\\ maturity\\ should\\ be\\ suspected\\ of\\ malignant\\ transformation\\.\\ \\ malignant\\ transformation\\ before\\ age\\ 20\\ is\\ unusual\\.\\ \\ suspect\\ malignant\\ transformation\\ if\\ the\\ thickness\\ of\\ the\\ cartilage\\ cap\\ of\\ an\\ osteochondroma\\ measures\\ more\\ than\\ 1\\.5\\ cm\\ in\\ a\\ skeletally\\ mature\\ patient\\.\\ pain\\ in\\ the\\ region\\ of\\ the\\ osteochondroma\\ may\\ be\\ a\\ result\\ of\\ pressure\\ of\\ the\\ osteochondroma\\ on\\ adjacent\\ tissues\\ with\\ local\\ inflammation\\ or\\ development\\ of\\ malignancy\\.\\ both\\ are\\ best\\ evaluated\\ by\\ mri\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ 1\\.\\ \\ murphey\\ md\\,\\ et\\ al\\.\\ \\ from\\ the\\ archives\\ of\\ the\\ afip\\:\\ imaging\\ of\\ osteochondroma\\:\\ variants\\ and\\ complications\\ with\\ radiologic\\-pathologic\\ correlation\\.\\ \\ radiographics\\ 2000\\;\\ 20\\:1407\\-1434\\.\ \(0\)\
\-\ 2\\.\\ \\ rajah\\ r\\,\\ tinkler\\ sa\\,\\ conway\\ wf\\.\\ \\ general\\ case\\ of\\ the\\ day\\.\\ \\ radiographics\\ 1995\\;\\ 15\\:1510\\-1512\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ osteochondromas\\:\\ 0\\.09235829673796246\ \(0\)\
\-\ osteochondroma\\:\\ 0\\.08542175560962274\ \(0\)\
\-\ transformation\\:\\ 0\\.04528249075153623\ \(0\)\
\-\ bone\\:\\ 0\\.039690367877754575\ \(0\)\
\-\ cap\\:\\ 0\\.030550780900822562\ \(0\)\
\-\ lesions\\:\\ 0\\.029930698213846047\ \(0\)\
\-\ continuity\\:\\ 0\\.029184675764423962\ \(0\)\
\-\ cartilage\\:\\ 0\\.024931236849529775\ \(0\)\
\-\ solitary\\:\\ 0\\.02378022866614831\ \(0\)\
\-\ involvement\\:\\ 0\\.023416363787871528\ \(0\)\
\-\ malignant\\:\\ 0\\.023092864870125615\ \(0\)\
\-\ maturity\\:\\ 0\\.02283165690790388\ \(0\)\
\-\ exostoses\\:\\ 0\\.022363757308075823\ \(0\)\
\-\ \\%\\:\\ 0\\.022355002243132794\ \(0\)\
\-\ case\\:\\ 0\\.020966404854586212\ \(0\)\
\-\ affected\\:\\ 0\\.02073378286850323\ \(0\)\
\-\ femur\\:\\ 0\\.020700305296616293\ \(0\)\
\-\ proximal\\:\\ 0\\.01918163126509918\ \(0\)\
\-\ symptomatic\\:\\ 0\\.01903729023193016\ \(0\)\
\-\ radiographics\\:\\ 0\\.01872469508110721\ \(0\)\
\-\ hereditary\\:\\ 0\\.018330823994535894\ \(0\)\
\-\ 1\\.6\\-3\\.4\\:\\ 0\\.0164776045307785\ \(0\)\
\-\ 20\\:1407\\-1434\\:\\ 0\\.0164776045307785\ \(0\)\
\-\ rajah\\:\\ 0\\.0164776045307785\ \(0\)\
\-\ tinkler\\:\\ 0\\.0164776045307785\ \(0\)\
\-\ 15\\:1510\\-1512\\:\\ 0\\.0164776045307785\ \(0\)\
\-\ lesion\\:\\ 0\\.016266871271032286\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.01619771438128647\ \(0\)\
\-\ 1\\.5\\:\\ 0\\.01597092950166914\ \(0\)\
\-\ skeletal\\:\\ 0\\.015777190930212744\ \(0\)\
\-\ medullary\\:\\ 0\\.015349488682819306\ \(0\)\
\-\ most\\:\\ 0\\.014750169283948233\ \(0\)\
\-\ conway\\:\\ 0\\.014424123617380165\ \(0\)\
\-\ this\\:\\ 0\\.014372145245818813\ \(0\)\
\-\ growth\\:\\ 0\\.01389028783604598\ \(0\)\
\-\ constitute\\:\\ 0\\.013886400117470296\ \(0\)\
\-\ sa\\:\\ 0\\.013886400117470296\ \(0\)\
\-\ underlying\\:\\ 0\\.01369056758679895\ \(0\)\
\-\ murphey\\:\\ 0\\.013469309367350277\ \(0\)\
\-\ multiple\\:\\ 0\\.01345649348395715\ \(0\)\
\-\ single\\:\\ 0\\.01294826276818853\ \(0\)\
\-\ skeletally\\:\\ 0\\.012840389298899411\ \(0\)\
\-\ archives\\:\\ 0\\.012840389298899411\ \(0\)\
\-\ afip\\:\\ 0\\.012840389298899411\ \(0\)\
\-\ radiologic\\-pathologic\\:\\ 0\\.012840389298899411\ \(0\)\
\-\ routine\\:\\ 0\\.012809146520186906\ \(0\)\
\-\ 20\\-50\\:\\ 0\\.01259079791081619\ \(0\)\
\-\ common\\:\\ 0\\.012539816141811572\ \(0\)\
\-\ base\\:\\ 0\\.012513862739556512\ \(0\)\
\-\ rare\\:\\ 0\\.012405047471675874\ \(0\)\
\-\ be\\:\\ 0\\.012315483395737655\ \(0\)\
\-\ tumors\\:\\ 0\\.011998939654842994\ \(0\)\
\-\ trochanter\\:\\ 0\\.011995557291903042\ \(0\)\
\-\ occur\\:\\ 0\\.011985221042173977\ \(0\)\
\-\ more\\:\\ 0\\.011984166220442053\ \(0\)\
\-\ in\\:\\ 0\\.011814875611409016\ \(0\)\
\-\ thighs\\:\\ 0\\.011683306666364414\ \(0\)\
\-\ cosmetic\\:\\ 0\\.011683306666364414\ \(0\)\
\-\ variants\\:\\ 0\\.011683306666364414\ \(0\)\
\-\ enlarge\\:\\ 0\\.011544787092245308\ \(0\)\
\-\ suspect\\:\\ 0\\.01141582845395194\ \(0\)\
\-\ reaching\\:\\ 0\\.011181878654037912\ \(0\)\
\-\ wf\\:\\ 0\\.011181878654037912\ \(0\)\
\-\ femurs\\:\\ 0\\.010973980270654314\ \(0\)\
\-\ ranging\\:\\ 0\\.010973980270654314\ \(0\)\
\-\ projects\\:\\ 0\\.010878104954042069\ \(0\)\
\-\ 10\\-15\\:\\ 0\\.010878104954042069\ \(0\)\
\-\ cases\\:\\ 0\\.010642283603667785\ \(0\)\
\-\ exhibit\\:\\ 0\\.010616867678574483\ \(0\)\
\-\ 2\\.0\\:\\ 0\\.010537316997417855\ \(0\)\
\-\ predilection\\:\\ 0\\.010537316997417855\ \(0\)\
\-\ stalk\\:\\ 0\\.010537316997417855\ \(0\)\
\-\ is\\:\\ 0\\.010510108007191132\ \(0\)\
\-\ grow\\:\\ 0\\.01038770445971031\ \(0\)\
\-\ 1995\\:\\ 0\\.009886276447383808\ \(0\)\
\-\ windows\\:\\ 0\\.009728225254807989\ \(0\)\
\-\ exophytic\\:\\ 0\\.009728225254807989\ \(0\)\
\-\ usually\\:\\ 0\\.009700666369595361\ \(0\)\
\-\ mature\\:\\ 0\\.009629825752966078\ \(0\)\
\-\ hips\\:\\ 0\\.009404352878594835\ \(0\)\
\-\ individuals\\:\\ 0\\.00932126547192038\ \(0\)\
\-\ younger\\:\\ 0\\.00932126547192038\ \(0\)\
\-\ estimated\\:\\ 0\\.009241714790763753\ \(0\)\
\-\ 2000\\:\\ 0\\.009241714790763753\ \(0\)\
\-\ his\\:\\ 0\\.009207061785596007\ \(0\)\
\-\ 1\\-2\\:\\ 0\\.009165411997267947\ \(0\)\
\-\ occurring\\:\\ 0\\.008920499357255978\ \(0\)\
\-\ conservatively\\:\\ 0\\.00888799142695342\ \(0\)\
\-\ an\\:\\ 0\\.00883487748997929\ \(0\)\
\-\ correlation\\:\\ 0\\.008793728149146144\ \(0\)\
\-\ the\\:\\ 0\\.008785935850323882\ \(0\)\
\-\ if\\:\\ 0\\.008668199752450974\ \(0\)\
\-\ pathognomonic\\:\\ 0\\.008646474171850603\ \(0\)\
\-\ diaphysis\\:\\ 0\\.008590674240729703\ \(0\)\
\-\ cm\\:\\ 0\\.008568060253521442\ \(0\)\
\-\ than\\:\\ 0\\.008370276093152426\ \(0\)\
\-\ these\\:\\ 0\\.008313438100776973\ \(0\)\
\-\ minimally\\:\\ 0\\.008310412283176593\ \(0\)\
\-\ osteosarcoma\\:\\ 0\\.008310412283176593\ \(0\)\
\-\ thickness\\:\\ 0\\.008240746124677093\ \(0\)\
\-\ nontender\\:\\ 0\\.008195703972192868\ \(0\)\
\-\ enlarging\\:\\ 0\\.008130112720209186\ \(0\)\
\-\ painless\\:\\ 0\\.008025663265266277\ \(0\)\
\-\ chondrosarcoma\\:\\ 0\\.00798546475083457\ \(0\)\
\-\ develop\\:\\ 0\\.00796568510722609\ \(0\)\
\-\ metaphysis\\:\\ 0\\.00794611258410965\ \(0\)\
\-\ resected\\:\\ 0\\.007907571860366218\ \(0\)\
\-\ md\\:\\ 0\\.007888595465106372\ \(0\)\
\-\ undergoing\\:\\ 0\\.00783279553398547\ \(0\)\
\-\ denied\\:\\ 0\\.007778613222072852\ \(0\)\
\-\ women\\:\\ 0\\.007760895943653143\ \(0\)\
\-\ times\\:\\ 0\\.0077433450271113865\ \(0\)\
\-\ unusual\\:\\ 0\\.007725957377275287\ \(0\)\
\-\ larger\\:\\ 0\\.0076916599218207135\ \(0\)\
\-\ 1\\:\\ 0\\.007601220067139092\ \(0\)\
\-\ \\;\\:\\ 0\\.007571667994215304\ \(0\)\
\-\ involve\\:\\ 0\\.007529021833989631\ \(0\)\
\-\ or\\:\\ 0\\.007488020552999683\ \(0\)\
\-\ local\\:\\ 0\\.007336765038775224\ \(0\)\
\-\ evaluated\\:\\ 0\\.007322763783206705\ \(0\)\
\-\ off\\:\\ 0\\.007295072034075601\ \(0\)\
\-\ r\\:\\ 0\\.007254288767917396\ \(0\)\
\-\ as\\:\\ 0\\.007248098163892305\ \(0\)\
\-\ can\\:\\ 0\\.0072456910372675504\ \(0\)\
\-\ from\\:\\ 0\\.007101508671892779\ \(0\)\
\-\ supportive\\:\\ 0\\.007062739853369849\ \(0\)\
\-\ may\\:\\ 0\\.00700683502391822\ \(0\)\
\-\ their\\:\\ 0\\.0069912983340797595\ \(0\)\
\-\ demonstrates\\:\\ 0\\.0069780231837502284\ \(0\)\
\-\ development\\:\\ 0\\.006956576118055582\ \(0\)\
\-\ below\\:\\ 0\\.006933781215076482\ \(0\)\
\-\ frequently\\:\\ 0\\.0069224871693644024\ \(0\)\
\-\ provided\\:\\ 0\\.006889008801950327\ \(0\)\
\-\ deformity\\:\\ 0\\.006877981283955582\ \(0\)\
\-\ suspected\\:\\ 0\\.006877981283955582\ \(0\)\
\-\ cortex\\:\\ 0\\.006834510513555083\ \(0\)\
\-\ measures\\:\\ 0\\.006834510513555083\ \(0\)\
\-\ inflammation\\:\\ 0\\.006792027801260586\ \(0\)\
\-\ osseous\\:\\ 0\\.006781556295562137\ \(0\)\
\-\ al\\:\\ 0\\.0067711431272453985\ \(0\)\
\-\ compared\\:\\ 0\\.006760787649907799\ \(0\)\
\-\ before\\:\\ 0\\.006760787649907799\ \(0\)\
\-\ bones\\:\\ 0\\.006740247235747809\ \(0\)\
\-\ general\\:\\ 0\\.006730061058612173\ \(0\)\
\-\ best\\:\\ 0\\.006719930091379764\ \(0\)\
\-\ just\\:\\ 0\\.006670082900571986\ \(0\)\
\-\ references\\:\\ 0\\.0066408004393675\ \(0\)\
\-\ arising\\:\\ 0\\.0066119696537121145\ \(0\)\
\-\ related\\:\\ 0\\.0065929932584522675\ \(0\)\
\-\ occurs\\:\\ 0\\.006555608834701483\ \(0\)\
\-\ tissues\\:\\ 0\\.006555608834701483\ \(0\)\
\-\ et\\:\\ 0\\.006537193327331368\ \(0\)\
\-\ are\\:\\ 0\\.006532003023530477\ \(0\)\
\-\ upon\\:\\ 0\\.006528053167902972\ \(0\)\
\-\ where\\:\\ 0\\.006518957486311995\ \(0\)\
\-\ at\\:\\ 0\\.0064921298289624275\ \(0\)\
\-\ patient\\:\\ 0\\.006404425651711313\ \(0\)\
\-\ canal\\:\\ 0\\.006345763410643387\ \(0\)\
\-\ \\:\\:\\ 0\\.0063379896223775605\ \(0\)\
\-\ complications\\:\\ 0\\.006329294943947771\ \(0\)\
\-\ pressure\\:\\ 0\\.0062727717940604475\ \(0\)\
\-\ malignancy\\:\\ 0\\.006172130238881338\ \(0\)\
\-\ 30\\:\\ 0\\.006142223058794533\ \(0\)\
\-\ result\\:\\ 0\\.006127447022332639\ \(0\)\
\-\ femoral\\:\\ 0\\.00607663180681085\ \(0\)\
\-\ 50\\:\\ 0\\.00607663180681085\ \(0\)\
\-\ radiographic\\:\\ 0\\.00606236334913782\ \(0\)\
\-\ incidental\\:\\ 0\\.00604820298687902\ \(0\)\
\-\ commonly\\:\\ 0\\.006027161576552601\ \(0\)\
\-\ greater\\:\\ 0\\.005999469827421497\ \(0\)\
\-\ which\\:\\ 0\\.005963157335486163\ \(0\)\
\-\ pain\\:\\ 0\\.005852008416060194\ \(0\)\
\-\ extremity\\:\\ 0\\.005841418634845679\ \(0\)\
\-\ cortical\\:\\ 0\\.005822569814160397\ \(0\)\
\-\ male\\:\\ 0\\.005776469300513919\ \(0\)\
\-\ care\\:\\ 0\\.005761078779567762\ \(0\)\
\-\ 20\\:\\ 0\\.005743019133003768\ \(0\)\
\-\ would\\:\\ 0\\.005684050240041289\ \(0\)\
\-\ benign\\:\\ 0\\.005512243676697573\ \(0\)\
\-\ long\\:\\ 0\\.005506956095014437\ \(0\)\
\-\ of\\:\\ 0\\.005444102841027497\ \(0\)\
\-\ cause\\:\\ 0\\.005404229208508348\ \(0\)\
\-\ three\\:\\ 0\\.0053843443520503\ \(0\)\
\-\ x\\:\\ 0\\.005269282869808369\ \(0\)\
\-\ a\\:\\ 0\\.005189156285477026\ \(0\)\
\-\ finding\\:\\ 0\\.0051477785140906195\ \(0\)\
\-\ should\\:\\ 0\\.00509197858296972\ \(0\)\
\-\ further\\:\\ 0\\.005079334844486464\ \(0\)\
\-\ 2\\.\\:\\ 0\\.005079334844486464\ \(0\)\
\-\ follow\\:\\ 0\\.005075139199899877\ \(0\)\
\-\ day\\:\\ 0\\.005070952952061551\ \(0\)\
\-\ adjacent\\:\\ 0\\.005050161203989285\ \(0\)\
\-\ any\\:\\ 0\\.005029598192658493\ \(0\)\
\-\ aspect\\:\\ 0\\.005017368101838051\ \(0\)\
\-\ 1\\.\\:\\ 0\\.0049891386285936465\ \(0\)\
\-\ approximately\\:\\ 0\\.004941715563655295\ \(0\)\
\-\ show\\:\\ 0\\.004903095204657245\ \(0\)\
\-\ age\\:\\ 0\\.004861514627185619\ \(0\)\
\-\ treated\\:\\ 0\\.004781029600156746\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.0047738817563466466\ \(0\)\
\-\ demonstrated\\:\\ 0\\.004686766322349472\ \(0\)\
\-\ evaluation\\:\\ 0\\.0046396986837884254\ \(0\)\
\-\ s\\:\\ 0\\.004580874144139415\ \(0\)\
\-\ when\\:\\ 0\\.004574450911431787\ \(0\)\
\-\ axial\\:\\ 0\\.0045584887403137785\ \(0\)\
\-\ \\,\\:\\ 0\\.004554001102159975\ \(0\)\
\-\ all\\:\\ 0\\.004517613998936992\ \(0\)\
\-\ region\\:\\ 0\\.004511404163064136\ \(0\)\
\-\ distal\\:\\ 0\\.004342576801768275\ \(0\)\
\-\ up\\:\\ 0\\.00429504140383967\ \(0\)\
\-\ due\\:\\ 0\\.004262200285893158\ \(0\)\
\-\ patients\\:\\ 0\\.004133784297880422\ \(0\)\
\-\ anterior\\:\\ 0\\.004113631446285491\ \(0\)\
\-\ both\\:\\ 0\\.004078878487263778\ \(0\)\
\-\ to\\:\\ 0\\.0039912907331120205\ \(0\)\
\-\ symptoms\\:\\ 0\\.003980668181118017\ \(0\)\
\-\ none\\:\\ 0\\.003962092536276648\ \(0\)\
\-\ imaging\\:\\ 0\\.003742194064402996\ \(0\)\
\-\ was\\:\\ 0\\.003694495410144624\ \(0\)\
\-\ small\\:\\ 0\\.0036795799708058295\ \(0\)\
\-\ mri\\:\\ 0\\.003669674495167514\ \(0\)\
\-\ diagnosis\\:\\ 0\\.0036676996837017198\ \(0\)\
\-\ were\\:\\ 0\\.0036267034330652735\ \(0\)\
\-\ lower\\:\\ 0\\.0035922655502128274\ \(0\)\
\-\ left\\:\\ 0\\.0035742253056931395\ \(0\)\
\-\ have\\:\\ 0\\.003458762763299237\ \(0\)\
\-\ after\\:\\ 0\\.00330467514506393\ \(0\)\
\-\ seen\\:\\ 0\\.0031563132991919447\ \(0\)\
\-\ that\\:\\ 0\\.0027588424832875203\ \(0\)\
\-\ for\\:\\ 0\\.0027256379388512714\ \(0\)\
\-\ by\\:\\ 0\\.0026595717817661214\ \(0\)\
\-\ \\.\\:\\ 0\\.002521462377007773\ \(0\)\
\-\ normal\\:\\ 0\\.002503948513269348\ \(0\)\
\-\ there\\:\\ 0\\.0023770384232990444\ \(0\)\
\-\ ct\\:\\ 0\\.0022342124362468093\ \(0\)\
\-\ mass\\:\\ 0\\.0022214224428926442\ \(0\)\
\-\ and\\:\\ 0\\.0020187925876510478\ \(0\)\
\-\ no\\:\\ 0\\.0016083068237454244\ \(0\)\
\-\ with\\:\\ 0\\.001530895761923791\ \(0\)\
\-\ on\\:\\ 0\\.001353067312832576\ \(0\)\
\-\ \\(\\:\\ 0\\.001350208834100674\ \(0\)\
\-\ \\)\\:\\ 0\\.0013337153123613179\ \(0\)\
